Results 111 to 120 of about 4,423,512 (307)

CLINICAL COURSE OF VULVAR CANCER IN REPRODUCTIVE PATIENTS

open access: yesКреативная хирургия и онкология, 2017
Incidence  of vulvar cancer  in reproductive patients and  peculiarities  of clinical course of the disease  have been  studied. 839  vulvar cancer  patients aged  20-90 years have been treated at Gynecology Department of Rostov Research Oncologic ...
G. A. Nerodo   +2 more
doaj   +1 more source

Genaue modellbasierte Identifikation von gynäkologischen Katheterpfaden für die MRT-bildgestützte Brachytherapie [PDF]

open access: yesarXiv, 2018
German text, english abstract: Mortality in gynecologic cancers, including cervical, ovarian, vaginal and vulvar cancers, is more than 6% internationally [1]. In many countries external radiotherapy is supplemented by brachytherapy with high locally administered doses as standard.
arxiv  

Three facets of mathematical cancer biology research [PDF]

open access: yesarXiv, 2023
Cancer, as the uncontrollable cell growth, is related to many branches of biology. In this review, we will discuss three mathematical approaches for studying cancer biology: population dynamics, gene regulation, and developmental biology. If we understand all biochemical mechanisms of cancer cells, we can directly calculate how the cancer cell ...
arxiv  

Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20‐17/KM23 trial

open access: yes
Cancer Communications, EarlyView.
Kyoungmin Lee   +20 more
wiley   +1 more source

Indocyanine green fluorescence‐guided sentinel lymph node biopsy: A systematic review

open access: yesWorld Journal of Otorhinolaryngology - Head and Neck Surgery, EarlyView.
Abstract Objectives Accurate staging of cervical lymph nodes is crucial in the management of head and neck cancers (HNCs). Sentinel lymph node biopsy (SLNB) offers a minimally invasive alternative to neck dissection for identifying occult metastases. This review aims to assess the feasibility and effectiveness of indocyanine green (ICG) fluorescence ...
Sanjena Venkatesh   +2 more
wiley   +1 more source

Electrochemotherapy as an Alternative Treatment Option to Pelvic Exenteration for Recurrent Vulvar Cancer of the Perineum Region

open access: yesTechnology in Cancer Research & Treatment, 2022
Objective : Pelvic exenteration in women with recurrent vulvar carcinoma is associated with high morbidity and mortality and substantial treatment costs.
Gregor Vivod MD   +7 more
doaj   +1 more source

Deep Learning Approach for Early Stage Lung Cancer Detection [PDF]

open access: yesarXiv, 2023
Lung cancer is the leading cause of death among different types of cancers. Every year, the lives lost due to lung cancer exceed those lost to pancreatic, breast, and prostate cancer combined. The survival rate for lung cancer patients is very low compared to other cancer patients due to late diagnostics.
arxiv  

Morbidity following Surgical Management of Vulval Cancer. [PDF]

open access: yes, 2012
The objective of this study was to know the complications following vulvectomy and inguinofemoral lymphadenectomy including the time taken to complete wound healing.
Bafna, UD   +4 more
core  

Topical imiquimod treatment of residual or recurrent cervical intraepithelial neoplasia lesions (TOPIC‐2): A randomised controlled trial

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
Abstract Objective To investigate the efficacy of imiquimod in women with residual or recurrent cervical intraepithelial neoplasia (rrCIN), compared with large loop excision of the transformation zone (LLETZ). Design Randomised controlled non‐inferiority trial. Setting One academic and one regional hospital in the Netherlands.
Anna J. M. van de Sande   +11 more
wiley   +1 more source

WNL we never looked: vulvar carcinoma incidence after screening cutoff

open access: yesInternational Journal of Women's Dermatology
The incidence of vulvar carcinoma increases with age, though elderly women receive less aggressive cancer therapies and fewer strategies aimed at cancer prevention.
Amaris N. Geisler, MD, Jodi E. Ganz, MD
doaj   +1 more source

Home - About - Disclaimer - Privacy